Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Palantir CEO Alex Karp asserts there was never a domestic surveillance plan in the Anthropic-DoD dispute, detailing t...
Naspers is quietly reducing its Remitly exposure, a move that speaks to broader priorities than a single stock. This ...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
The latest consumer sentiment 56.4 reading sets the tone for retail stocks and the VanEck Retail ETF (RTH) in 2026. I...
Analysts released a fresh batch of top calls on Thursday, reshaping sentiment across industrials and tech as earnings...
Investors are shifting money toward growth initiatives, pressuring companies to expand and innovate instead of increa...
As 2026 unfolds, Resideo's earnings trajectory blends hardware sales with growing recurring revenue. This guide break...
Hedge fund founder Jeffrey Gundlach warns the Fed won’t cut rates at the upcoming meeting amid stubborn inflation, hi...
Target reports its strongest quarterly gain in comparable sales in four years, signaling progress in a broad turnarou...
A former Google engineer turned $7.2 AI CEO says the hiring surge is real, but the toughest filter is drive and work ...